Zoetis (ZTS) Hits New 52-Week Low on Dismal Outlook

We recently published 10 Stocks Lead Wall Street Downward Spiral. Zoetis Inc. (NYSE:ZTS) is one of the worst-performing stocks on Tuesday.

Zoetis fell to a new 52-week low on Tuesday, as investor sentiment was dampened by a lower revenue growth outlook for full-year 2025.

In intra-day trading, Zoetis Inc. (NYSE:ZTS) dropped to its lowest price of $122.03 before trimming gains to end the day just down by 13.78 percent at $124.46 apiece, after revenue guidance for full-year 2025 was reduced to a range of $9.4 billion to $9.475 billion from $9.45 billion to $9.6 billion projected previously.

Net income outlook was also lowered to a range of $2.625 billion to $2.665 billion from $2.65 billion to $2.7 billion prior.

In the third quarter of the year, Zoetis Inc. (NYSE:ZTS) grew its attributable net income by 5.7 percent to $721 million from $682 million, while revenues ended flat at $2.4 billion.

“While growth moderated in the third quarter in line with our expectations, we achieved significant regulatory milestones, including major new product approvals, geographic expansions and differentiating lifecycle innovations across products and species. With our manufacturing excellence, strong customer relationships and a robust pipeline, we are well positioned to advance animal care, bring new products to market and deliver sustainable growth and value for our shareholders,” said Zoetis Inc. (NYSE:ZTS) CEO Kristin Peck.

While we acknowledge the potential of ZTS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.